| Patents for C12P 21 - Preparation of peptides or proteins (112,499) | 
|---|
| 10/15/2013 | US8557964 Anti CXCR4 antibodies and their use for the treatment of cancer | 
| 10/15/2013 | US8557562 Yeast with increased butanol tolerance involving filamentous growth response | 
| 10/15/2013 | US8557557 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from Alicyclobacillus acidocaldarius and related organisms, methods | 
| 10/15/2013 | US8557548 Compositions relating to a mutant Clostridium difficile toxin and methods thereof | 
| 10/15/2013 | US8557547 Phosphotriesterase from agrobacterium radiobacter P230 | 
| 10/15/2013 | US8557545 Modified phosphatases | 
| 10/15/2013 | US8557542 Methods for ribosomal synthesis of polypeptides containing unnatural N-terminal groups and applications thereof | 
| 10/15/2013 | US8557245 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody | 
| 10/15/2013 | US8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody | 
| 10/15/2013 | CA2589951C Method for producing carboxy-terminal amidated peptides | 
| 10/15/2013 | CA2548942C Anti-sars monoclonal antibodies | 
| 10/15/2013 | CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof | 
| 10/15/2013 | CA2410762C Feline hepatocyte growth factor | 
| 10/15/2013 | CA2373721C Compounds that bind her2 | 
| 10/10/2013 | WO2013150680A1 Protein tag, tagged protein, and protein purification method | 
| 10/10/2013 | WO2013150623A1 Conjugate of anti-cdh3 (p-cadherin) antibody and drug | 
| 10/10/2013 | WO2013138351A8 Separatome-based protein expression and purification platform | 
| 10/10/2013 | US20130267684 Method for preparing aqueous solution containing culture medium and chelating agent | 
| 10/10/2013 | US20130267683 Plant protein hydrolysates | 
| 10/10/2013 | US20130267468 Factor viii glycoforms | 
| 10/10/2013 | US20130266985 Process for Cell Culturing by Continuous Perfusion | 
| 10/10/2013 | US20130266984 Filamentous fungi with inactivated protease genes for altered protein production | 
| 10/10/2013 | US20130266982 Method of producing biologically active vitamin k dependent proteins by recombinant methods | 
| 10/10/2013 | US20130266981 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells | 
| 10/10/2013 | US20130266581 Anti-vegf antibodies | 
| 10/10/2013 | US20130266573 Specific binding proteins and uses thereof | 
| 10/09/2013 | EP2647721A1 Peptide with safer secondary structure, peptide library, and production methods for same | 
| 10/09/2013 | EP2647720A1 Peptide library production method, peptide library, and screening method | 
| 10/09/2013 | EP2647706A1 Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly | 
| 10/09/2013 | EP2647705A1 Flavin-bound glucose dehyrogenase, production method for flavin-bound glucose dehyrogenase, and yeast transformant used in same | 
| 10/09/2013 | EP2647704A1 Polynucleotide construct capable of presenting fab in acellular translation system, and method for manufacturing and screening fab using same | 
| 10/09/2013 | EP2647703A1 E. coli transformant, production method for flavin-bound glucose dehydrogenase using same, and mutant flavin-bound glucose dehydrogenase | 
| 10/09/2013 | EP2646472A1 Covalently dimerized bivalent binding agents | 
| 10/09/2013 | EP2646053A2 Compositions and methods for treating amyloid plaque associated symptoms | 
| 10/09/2013 | CN103348014A Yeast and yeast extract containing Gammar-glu-abu, and method for producing the yeast or yeast extract containing Gammar-glu-abu | 
| 10/09/2013 | CN103348011A Alpha-mannosidases from plant and method for using same | 
| 10/09/2013 | CN103348003A Fusion enzymes having N-acetylglucosaminyl transferase activity | 
| 10/09/2013 | CN103343154A Preparation of soybean anti-fatigue biological active peptide | 
| 10/09/2013 | CN103343153A Method for preparing forest frog oil peptides by enzymatic hydrolysis and forest frog oil peptides | 
| 10/09/2013 | CN103343046A Method for preparing oil and protein by cold pressing and enzymolysis of sesame | 
| 10/09/2013 | CN103342762A Process for coproduction of heparin sodium and intestine membrane protein | 
| 10/09/2013 | CN102851272B Gamma-glutamyltranspeptidase immobilized enzyme, preparation method and application thereof | 
| 10/09/2013 | CN102747097B I type human collagen and epidermal growth factor dual expression vector, and expression purification method thereof | 
| 10/09/2013 | CN102304540B Expression equipment for expressing exogenous protein by secretion in trichoderma reesei and application of expression equipment | 
| 10/09/2013 | CN101906154B Protein for adjusting green turning process of plant leave as well as coding gene and application thereof | 
| 10/08/2013 | US8552170 Expression vector for establishing highly productive cell and the highly productive cell | 
| 10/08/2013 | US8552168 Nucleic acids for inducing expression of transcripts and proteins and methods for making and using them | 
| 10/08/2013 | US8552159 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy | 
| 10/08/2013 | US8552158 Method for the production of insulin-like growth factor-1 | 
| 10/08/2013 | US8552146 Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides | 
| 10/08/2013 | US8551735 Method of diagnosing gastric cancer by using human neutrophil peptide 1-3 | 
| 10/08/2013 | US8551734 Selection and enrichment of proteins using in vitro compartmentalization | 
| 10/08/2013 | US8551733 Production of oligoclonal mixtures of immunoglobulins in single cells | 
| 10/08/2013 | US8551715 Methods for identifying and isolating cells expressing a polypeptide | 
| 10/08/2013 | US8551699 PCA3, PCA3 genes, and methods of use | 
| 10/08/2013 | US8551484 Human antibodies against hepatitis C virus (HCV) and uses thereof | 
| 10/08/2013 | US8551481 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody | 
| 10/08/2013 | CA2482769C "doping" in walk-through mutagenesis | 
| 10/08/2013 | CA2349839C Ucp5 | 
| 10/08/2013 | CA2238893C Il-13 receptor polypeptide | 
| 10/03/2013 | WO2013148249A1 Improved harvest operations for recombinant proteins | 
| 10/03/2013 | WO2013148117A1 Compositions and methods of use for treating metabolic disorders | 
| 10/03/2013 | WO2013148049A1 Recombinant cytotoxic t-lymphocyte-associated protein 4 (ctla4) | 
| 10/03/2013 | WO2013147213A1 Anti-siglec15 antibody with modified cdr | 
| 10/03/2013 | WO2013147212A1 Novel anti-siglec15 antibody | 
| 10/03/2013 | WO2013147153A1 Anti-lamp5 antibody and utilization thereof | 
| 10/03/2013 | WO2013144685A1 Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly | 
| 10/03/2013 | WO2013143504A1 Peptide and antibody libraries and uses thereof | 
| 10/03/2013 | WO2013143497A1 High purity cyclopeptide compound as well as preparation method and use thereof | 
| 10/03/2013 | WO2012047583A3 Antibodies binding human collagen ii | 
| 10/03/2013 | US20130261290 Method for preparative in vitro protein biosynthesis | 
| 10/03/2013 | US20130260994 Transgenic plants expressing modified cry3a | 
| 10/03/2013 | US20130260419 Continuous processing methods for biological products | 
| 10/03/2013 | US20130255003 Engineered leather and methods of manufacture thereof | 
| 10/02/2013 | EP2644698A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii | 
| 10/02/2013 | EP2643469A1 Stable preserved compositions of interferon-beta | 
| 10/02/2013 | EP2643468A2 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins | 
| 10/02/2013 | CN103339255A Method for producing proteins | 
| 10/02/2013 | CN103339140A Expression of soluble viral fusion glycoproteins in mammalian cells | 
| 10/02/2013 | CN103338786A Compositions and methods for treating amyloid plaque associated symptoms | 
| 10/02/2013 | CN103333941A High purity cerebrolysin vial injection preparation agent | 
| 10/02/2013 | CN103333940A Method for preparing dipeptidyl peptidase IV (DPP-IV) inhibitory peptide through using hairtail | 
| 10/02/2013 | CN103333939A Method for preparing gelatin from bone collagen fibers by alkali-enzyme composite degradation | 
| 10/02/2013 | CN103333938A Recombinant saccharomyces-fermentum-expressed hepatitis B surface antigen, production method of hepatitis B surface antigen, hepatitis B vaccine and production method of hepatitis B vaccine | 
| 10/02/2013 | CN103333937A Technique for preparing antimicrobial peptide by using Bacillus subtilis | 
| 10/02/2013 | CN103333912A Method for implementing constitutive expression of plectasin derivative MP1102 in Pichia pastoris | 
| 10/02/2013 | CN103333911A Method for producing protein A by utilizing recombinant pichia pastoris | 
| 10/02/2013 | CN103333860A Cells producing antibody compositions | 
| 10/02/2013 | CN103333806A Aspergillus oryzae with high protease yield, protease produced by using aspergillus oryzae and application of protease | 
| 10/02/2013 | CN103333221A Method for producing fish protein and fish protein peptide | 
| 10/02/2013 | CN103331454A Nano-silver manufacturing technology | 
| 10/02/2013 | CN103331127A Biosurfactant and preparation method thereof | 
| 10/02/2013 | CN102676624B Method for producing active peptide from peanut cake and meal by immobilized enzyme | 
| 10/02/2013 | CN102379435B Peanut polypeptide liquid and peanut protein polypeptide beverage prepared from the peanut polypeptide liquid | 
| 10/02/2013 | CN101534861B Polyalkylene oxides having hindered ester-based biodegradable linkers | 
| 10/02/2013 | CN101522705B Antibacterial and antiviral peptides from actinomadura namibiensis | 
| 10/01/2013 | USRE44512 Methods for producing recombinant proteins | 
| 10/01/2013 | US8546546 Anti-Muc 17 antibody | 
| 10/01/2013 | US8546539 Fc receptor-binding polypeptides with modified effector functions | 
| 10/01/2013 | US8546331 Modulation of pathogenic CD14+/CD16+ monocytes |